Pfizer reported data showing that its coronavirus vaccine had a 90.7% efficacy rate in preventing symptomatic Covid-19 in a clinical trial of 5- to 11-year-olds, a finding that may lead to the first authorization of a vaccine to protect young children.
The FDA's documents on the use of the Pfizer-BioNTech vaccine in kids aged 5-12 is up. Link here: FDA staff say the benefit of the vaccine in preventing Covid-19 outweighs the risk of myocarditis. 1/3
Children in the United States as young as five-years-old could soon be eligible for the COVID-19 vaccine after a new study revealed the Pfizer vaccine is safe.
Access to Covid booster shots is picking up here in #SoutheastTexas . The CDC has approved booster shots for Pfizer, Moderna and Johnson & Johnson and is allowing people to mix-and-match the shots. KFDM's Angel San Juan has the report.
Beginning Monday, the City of El Paso will now administer COVID-19 booster vaccine doses of Moderna and Johnson & Johnson/Janssen in addition to the Pfizer-BioNTech by appointment for eligible individuals.
Raleigh pediatrician weighs in on Pfizer COVID-19 vaccine findings
Yes, me too. Pfizer and a flu shot Monday. No side effects. All good.
Truth bomb! Pfizer scientists candidly admit naturally acquired immunity to COVID equal to or better than vaccine.